Ozempic and its Protective Factors in Relation to Acute Myocardial Infarction

Authors

  • Katryne Ferreira Rodrigues Correa

  • Laislenen Rachurat

  • Samara de Lima Silva

  • Maria Luísa Ginuino Carvalho

  • Ana Amélia Athaydes Clusella de Mello

  • Amanda Yanaze

  • Luciane Alves de Oliveira

  • João Vitor Rocha Alves

  • Eduardo Fernandes Rodrigues

  • Letícia Maria Dias Nobrega

  • Vanessa Siqueira Batista de Oliveira

  • Raphael Vinicius Mendes Abreu

DOI:

https://doi.org/10.34257/GJMRFVOL23IS9PG1

Keywords:

Abstract

Introduction The World Health Organization WHO estimates that cardiovascular diseases account for 31 of all deaths each year making them the leading cause of death worldwide As such the search to reduce rates through the development of new treatments and approaches is incessant Methodology This is a literature review whose bases were taken from the SciELO and PubMed data platforms The search period was July 2023 meeting the inclusion criteria of articles from 2000 to 2023 in Portuguese and English online and in full text Discussion Cardiovascular diseases CVD are the leading cause of death worldwide and are among the main causes of disability and years of life lost having an important social economic and quality of life impact on the population 1 2 Cardiovascular risk factors include high cholesterol levels diabetes mellitus a sedentary lifestyle high blood pressure and obesity

How to Cite

Katryne Ferreira Rodrigues Correa, Laislenen Rachurat, Samara de Lima Silva, Maria Luísa Ginuino Carvalho, Ana Amélia Athaydes Clusella de Mello, Amanda Yanaze, … Raphael Vinicius Mendes Abreu. (2023). Ozempic and its Protective Factors in Relation to Acute Myocardial Infarction. Global Journal of Medical Research, 23(F9), 1–2. https://doi.org/10.34257/GJMRFVOL23IS9PG1

Ozempic and its Protective Factors in Relation to Acute Myocardial Infarction

Published

2023-12-27